Incidence and survival patterns of clear cell renal cell carcinoma from 2000 to 2017: A SEER Database Analysis

被引:0
|
作者
Zou, Sijue [2 ]
Cui, Liwen [1 ]
Pai, Pearl [1 ]
Lu, Yiping [1 ]
Li, Xiangyang [1 ]
Wang, Gang [1 ]
Huang, Wen [1 ]
Wang, Dan [3 ]
Shaikh, Nikhat [4 ,5 ]
Peng, Zhangzhe [2 ]
Peng, Zhuoming [6 ]
He, Haiyan [1 ]
Liao, Zhouning [1 ]
机构
[1] Univ Hong Kong, Shenzhen Hosp, Dept Nephrol, Shenzhen, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Dept Nephrol, Changsha, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Dept Gen Surg, Changsha, Peoples R China
[4] Univ Med Ctr Hamburg Eppendorf, Dept Med, Hamburg, Germany
[5] Univ Med Ctr Hamburg Eppendorf, Hamburg Ctr Translat Immunol, Hamburg, Germany
[6] Huazhong Univ Sci & Technol, Union Shenzhen Hosp, Dept Resp & Intens Care Med, Shenzhen 518000, Guangdong, Peoples R China
来源
JOURNAL OF CANCER | 2025年 / 16卷 / 05期
关键词
SEER; Clear cell renal cell carcinoma; Incidence; Age mortality;
D O I
10.7150/jca.105713
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Clear cell renal cell carcinoma (ccRCC) incidence and death have considerably changed in recent years. Our study aimed to investigate the incidence, survival, and tumor characteristics of ccRCC in the year of diagnosis. Methods: Our study participants were selected from the SEER database (2000-2017). Age-standardized incidence rates were calculated to compare incidence rates across time. In addition, we used Kaplan-Meier curves to calculate overall survival (OS) and Cox proportional hazards models to explore risk factors associated with mortality outcomes in patients with ccRCC. Results: In the SEER analysis from 2000 to 2017, the increasing trend in age-adjusted incidence of ccRCC has remained relatively stable over the years, increasing from 2.63 per 100,000 in 2000 to 8.79 per 100,000 in 2017. The increase in the incidence of patients at a localized stage plays a decisive role in the overall increase in the incidence of ccRCC. Conclusions: In the general population, patients diagnosed between 2009-2017 had a higher survival rate than those diagnosed between 2000-2008, which is consistent with all stages of the tumor. The incidence of ccRCC increases steadily with the year of diagnosis, while overall survival has significantly improved.
引用
收藏
页码:1591 / 1597
页数:7
相关论文
共 50 条
  • [21] Epigenetic signature predicts overall survival clear cell renal cell carcinoma
    Yejinpeng Wang
    Liang Chen
    Lingao Ju
    Kaiyu Qian
    Xinghuan Wang
    Yu Xiao
    Gang Wang
    Cancer Cell International, 20
  • [22] Clear Cell Renal Cell Carcinoma: From Biology to Treatment
    Kase, Adam M.
    George, Daniel J.
    Ramalingam, Sundhar
    CANCERS, 2023, 15 (03)
  • [23] Radiomics Analysis of Contrast-Enhanced CT Predicts Survival in Clear Cell Renal Cell Carcinoma
    Yan, Lei
    Yang, Guangjie
    Cui, Jingjing
    Miao, Wenjie
    Wang, Yangyang
    Zhao, Yujun
    Wang, Ning
    Gong, Aidi
    Guo, Na
    Nie, Pei
    Wang, Zhenguang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [24] Breast metastasis from clear cell renal cell carcinoma
    Botticelli A.
    De Francesco G.P.
    Di Stefano D.
    Journal of Ultrasound, 2013, 16 (3) : 127 - 130
  • [25] Nomogram for predicting cancer-specific survival of patients with clear-cell renal cell carcinoma: a SEER-based population study
    Wang, Junhu
    Wen, Qian
    Wang, Xinwen
    Liu, Cheng
    Zhao, Kai
    Li, Yi
    Yang, Jie
    Liang, Xiaojun
    GENERAL PHYSIOLOGY AND BIOPHYSICS, 2022, 41 (06) : 591 - 601
  • [26] Identification of biomarkers of clear cell renal cell carcinoma by bioinformatics analysis
    Zhang, Ning
    Chen, Wenxin
    Gan, Zhilu
    Abudurexiti, Alimujiang
    Hu, Xiaogang
    Sang, Wei
    MEDICINE, 2020, 99 (21) : E20470
  • [27] Parathyroid Carcinoma: Incidence, Survival Analysis, and Management: A Study from the SEER Database and Insights into Future Therapeutic Perspectives
    Ullah, Asad
    Khan, Jaffar
    Waheed, Abdul
    Sharma, Nitasha
    Pryor, Elizabeth K.
    Stumpe, Tanner R.
    Zarate, Luis Velasquez
    Cason, Frederick D.
    Kumar, Suresh
    Misra, Subhasis
    Kavuri, Sravan
    Mesa, Hector
    Roper, Nitin
    Foroutan, Shahin
    Karki, Nabin Raj
    Del Rivero, Jaydira
    Simonds, William F.
    Karim, Nagla Abdel
    CANCERS, 2022, 14 (06)
  • [28] Trends in the Incidence and Survival Outcomes in Patients With Small Cell Lung Cancer in the United States: An Analysis of the SEER Database
    Uprety, Dipesh
    Seaton, Randell
    Niroula, Abesh
    Hadid, Tarik
    Parikh, Kaushal
    Ruterbusch, Julie J.
    CANCER MEDICINE, 2025, 14 (03):
  • [29] Cell heterogeneity in clear cell renal cell carcinoma
    Lopez, Jose I.
    Guarch, Rosa
    Larrinaga, Gorka
    Corominas-Cishek, Alexandra
    Orozco, Roberto
    APMIS, 2013, 121 (12) : 1187 - 1191
  • [30] Examining Racial Disparities in Primary Myelofibrosis Incidence and Survival Rates: A SEER Database Analysis from 2000-2019
    Hammami, M. Bakri
    Vegivinti, Charan
    Thakur, Rahul
    Qasim, Asma
    Verma, Amit
    Goel, Swati
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S396 - S396